Posts

STAT+: Pharmalittle: Novartis R&D hub’s name change ref...

Novartis is changing the name — and the guiding strategy — of its research and d...

Bacteria generate electricity from wastewater

“We engineered E. coli bacteria, the most widely studied microbe, to generate el...

Ballet of the brain: Unlocking the choreography of move...

The zebrafish brain, though simpler than its human counterpart, is a complex net...

Printers’ widows in early modern Germany

The historian Dr Saskia Limbach at the University of Göttingen has received a St...

Exiting the pandemic together: achieving global immunit...

“While vaccination has been successful for the general population, it is crucial...

Study hints at the existence of the closest black holes...

A paper published in the journal Monthly Notices of the Royal Astronomical Socie...

New program to connect entrepreneurs with national labo...

Oak Ridge National Laboratory has launched a new entrepreneurial start-up progra...

‘Brainless’ robot can navigate complex obstacles

Researchers who created a soft robot that could navigate simple mazes without hu...

McWilliams School of Biomedical Informatics researchers...

A three-year, $3.4 million grant to investigate how Alzheimer’s disease is conne...

Rice helps lead national quantum computing research eff...

HOUSTON – (Sept. 8, 2023) A team of Rice University researchers have won a 4-yea...

These worms have rhythm

There’s a rhythm to developing life. Growing from a tiny cell cluster into an ad...

A precision-health approach to bipolar disorder

The Brain & Behavior Research Foundation (BBRF) is hosting a free webinar, “A Pr...

More cases of breast cancer detected with the help of AI

One radiologist supported by AI detected more cases of breast cancer in screenin...

Study reveals human destruction of global floodplains

A University of Texas at Arlington hydrologist’s study in the Nature journal Sci...

Revvity introduces advanced preclinical imaging tech fo...

Revvity, Inc. is ushering in a new era of innovation in the realm of preclinical...

AstraZeneca mulls risk strategy for Ultomiris following...

The US FDA has requested that AstraZeneca make modifications to the Ultomiris RE...